Literature DB >> 12915533

Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.

A Goff1, L S Ehrlich, S N Cohen, C A Carter.   

Abstract

The structural precursor polyprotein of human immunodeficiency virus type 1, Pr55(gag), contains a proline-rich motif (PTAP) called the "late domain" in its C-terminal p6 region that directs release of mature virus-like particles (VLPs) from the plasma membranes of gag-transfected COS-1 cells. The motif binds Tsg101 (vacuolar protein-sorting protein 23, or Vps23), which functions in endocytic trafficking. Here, we show that accumulation of the wild-type (wt) Gag precursor in a fraction of COS-1 cytoplasm enriched in multivesicular bodies and small particulate components of the plasma membrane (P100) is p6 dependent. Cleavage intermediates and mature CA mainly partitioned with more rapidly sedimenting larger material enriched in components of lysosomes and early endosomes (P27), and this also was p6 dependent. Expression of truncated or full-length Tsg101 proteins interfered with VLP assembly and Gag accumulation in the P100 fraction. This correlated with reduced accumulation of Gag tagged with green fluorescent protein (Gag-GFP) at the plasma membrane and colocalization with the tagged Tsg101 in perinuclear early endosomes, as visualized by confocal microscopy. Fractionation analysis and confocal examination both indicated that the N-terminal region of Tsg101, which contains binding sites for PTAP and ubiquitin (Ub), was required for Gag trafficking to the plasma membrane. Expression of FLAG-tagged Tsg101 with a deletion in the Ub-binding pocket inhibited VLP release almost completely and to a significantly greater extent than expression of the wt tagged Tsg101 protein or Tsg101-FLAG containing a deletion in the PTAP-binding region. The results demonstrate that Gag associates with endosomal trafficking compartments and indicate that efficient release of virus particles from the plasma membrane requires both the PTAP- and Ub-binding functions of Tsg101 to recruit the cellular machinery required for budding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915533      PMCID: PMC187429          DOI: 10.1128/jvi.77.17.9173-9182.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins.

Authors:  A B Hittelman; D Burakov; J A Iñiguez-Lluhí; L P Freedman; M J Garabedian
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

2.  Role of ESCRT-I in retroviral budding.

Authors:  Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.

Authors:  A J Smith; M I Cho; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Tumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300.

Authors:  Z Sun; J Pan; W X Hope; S N Cohen; S P Balk
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

7.  Tsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag.

Authors:  Erin L Myers; Jane F Allen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24).

Authors:  L S Ehrlich; H G Krausslich; E Wimmer; C A Carter
Journal:  AIDS Res Hum Retroviruses       Date:  1990-10       Impact factor: 2.205

9.  Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization.

Authors:  L Alland; S M Peseckis; R E Atherton; L Berthiaume; M D Resh
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

10.  Yeast mutants affecting possible quality control of plasma membrane proteins.

Authors:  Y Li; T Kane; C Tipper; P Spatrick; D D Jenness
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

View more
  54 in total

Review 1.  Emerging drug targets for antiretroviral therapy.

Authors:  Jacqueline D Reeves; Andrew J Piefer
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.

Authors:  Marc C Johnson; Jared L Spidel; Danso Ako-Adjei; John W Wills; Volker M Vogt
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.

Authors:  Gisselle Medina; Yongjun Zhang; Yi Tang; Eva Gottwein; Marcy L Vana; Fadila Bouamr; Jonathan Leis; Carol A Carter
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

5.  Structural basis for endosomal targeting by the Bro1 domain.

Authors:  Jaewon Kim; Sujatha Sitaraman; Aitor Hierro; Bridgette M Beach; Greg Odorizzi; James H Hurley
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

6.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

7.  Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress.

Authors:  Dorothée Molle; Carolina Segura-Morales; Gregory Camus; Clarisse Berlioz-Torrent; Jorgen Kjems; Eugenia Basyuk; Edouard Bertrand
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

8.  Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.

Authors:  Kirsi Harila; Ian Prior; Mathilda Sjöberg; Antti Salminen; Jorma Hinkula; Maarit Suomalainen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi; Kunio Nagashima
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

10.  The Mechanism of Budding of Retroviruses From Cell Membranes.

Authors:  Andrew Pincetic; Jonathan Leis
Journal:  Adv Virol       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.